BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14981831)

  • 1. [Preliminary study on preparation and pharmaceutic features of adrimycin-loaded human serum albumin microspheres].
    Liu XB; Cai MY; Gong Y; Zhang ZR; Wei DP; Wang X; Li G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):107-9, 137. PubMed ID: 14981831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Internalization of antibody-targeted immunonanoparticles into human hepatoma cells and its reversal effect on MDR].
    Liu X; Wang X; Wei D; Cai M; Li G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):431-4. PubMed ID: 12910681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preparation and in vitro killing effect of adriamycin-loaded immunonanosphere against hepatoma led by F (ab')2 Fragment of monoclonal antibodies].
    Li Y; Cai M; Wang Z; Liu X; Liang Z
    Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):8-11, 14. PubMed ID: 12599415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles.
    Dreis S; Rothweiler F; Michaelis M; Cinatl J; Kreuter J; Langer K
    Int J Pharm; 2007 Aug; 341(1-2):207-14. PubMed ID: 17478065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on mitoxantrone albumin microspheres for liver targeting].
    Zhang ZR; Qian WJ
    Yao Xue Xue Bao; 1997; 32(1):72-8. PubMed ID: 11243225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of adriamycin antitumor activity by its binding with an intracellular sustained-release form, polymethacrylate nanospheres, in U-937 cells.
    Astier A; Doat B; Ferrer MJ; Benoit G; Fleury J; Rolland A; Leverge R
    Cancer Res; 1988 Apr; 48(7):1835-41. PubMed ID: 2894892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coupling of lactose molecules to the carrier protein hinders the spleen and bone marrow uptake of doxorubicin conjugated with human albumin.
    Di Stefano G; Fiume L; Baglioni M; Busi C; Chieco P; Kratz F; Mattioli A
    Eur J Pharm Sci; 2007 Feb; 30(2):136-42. PubMed ID: 17218086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of human serum albumin microspheres by a novel acetone-heat denaturation method.
    Chen CQ; Lin W; Coombes AG; Davis SS; Illum L
    J Microencapsul; 1994; 11(4):395-407. PubMed ID: 7931939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and cytotoxicity of doxorubicin loaded in self-assembled bio-polyelectrolyte microshells.
    Tao X; Chen H; Sun XJ; Chen JF; Roa WH
    Int J Pharm; 2007 May; 336(2):376-81. PubMed ID: 17223293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on preparation and characteristics of cisplatin chitosan microspheres].
    Wang YM; Shi TS; Pu YL; Zhu JG; Zhao YL
    Yao Xue Xue Bao; 1996; 31(4):300-5. PubMed ID: 9208650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of nanosized Fe3O4 in anticancer drug carriers with target-orientation and sustained-release properties.
    Lin BL; Shen XD; Cui S
    Biomed Mater; 2007 Jun; 2(2):132-4. PubMed ID: 18458446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of post-emulsification drying processes on the microencapsulation of human serum albumin.
    Lane ME; Brennan FS; Corrigan OI
    Int J Pharm; 2006 Jan; 307(1):16-22. PubMed ID: 16274944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the specific killing activity of albumin nanoparticles containing adriamycin targeted by monoclonal antibody BDI-1 to human bladder cancer cells].
    Sheng J; Samten BK; Xie SS; Wei SL
    Yao Xue Xue Bao; 1995; 30(9):706-10. PubMed ID: 8701747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of neferine on adriamycin-resistance of thermotolerant hepatocarcinoma cell line HepG2/thermotolerance].
    Ai XH; Tang XQ; Liu YP; Liu HQ; Dong L
    Ai Zheng; 2007 Apr; 26(4):357-60. PubMed ID: 17430651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization and performance evaluation of neomycin-HSA microspheres.
    Pande S; Vyas S; Dixit V
    J Microencapsul; 1990; 7(2):155-65. PubMed ID: 2329442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research on carboxymethyl chitosan acting as the adjuvant for implantable degradable microspheres].
    Yin C; Hou C; Jiang L; Gu Q
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):350-4. PubMed ID: 15250131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The internalization of immunotargeting drugs for hepatocellar carcinoma and its significance].
    Sui Y; Sun Z; Chen Z
    Zhonghua Yi Xue Za Zhi; 1996 Nov; 76(11):845-7. PubMed ID: 9275537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of uniform sized chitosan microspheres by membrane emulsification technique and application as a carrier of protein drug.
    Wang LY; Ma GH; Su ZG
    J Control Release; 2005 Aug; 106(1-2):62-75. PubMed ID: 15922472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on drug release after arterial embolism with cisplain-loaded albumin microspheres in treating carcinoma of tongue].
    Li H; Wen Y; Wang C
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Apr; 21(2):112-3, 139. PubMed ID: 12838693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study.
    He Y; Liu Y; Liu Y; Wang J; Zhang X; Lu W; Ma Z; Zhu X; Zhang Q
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3983-8. PubMed ID: 16936114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.